National Amyloidosis Centre, Division of Medicine, University College London, Rowland Hill Street, London, NW3 2PF, UK.
Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, Pond Street, London, NW3 2QG, UK.
Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1344-1350. doi: 10.1093/ehjci/jew325.
High-grade (Perugini grade 2 or 3) cardiac uptake on bone scintigraphy with 99mTechnetium labelled 3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) has lately been confirmed to have high diagnostic sensitivity and specificity for cardiac transthyretin (ATTR) amyloidosis. We sought to determine whether patient stratification by Perugini grade on 99mTc-DPD scintigraphy has prognostic significance in ATTR amyloidosis.
Patient survival from time of 99mTc-DPD scintigraphy was determined in 602 patients with ATTR amyloidosis, including 377 with wild-type ATTR (ATTRwt) and 225 with mutant ATTR (ATTRm) amyloidosis. Patients were stratified according to Perugini grade (0-3) on 99mTc-DPD scan. The prognostic significance of additional patient and disease-related factors at baseline were determined. In the whole cohort, the finding of a Perugini grade 0 99mTc-DPD scan (n = 28) was invariably associated with absence of cardiac amyloid according to consensus criteria as well as significantly better patient survival compared to a Perugini grade 1 (n = 28), 2 (n = 436) or 3 (n = 110) 99mTc-DPD scan (P < 0.005). There were no differences in survival between patients with a grade 1, grade 2 or grade 3 99mTc-DPD scan in ATTRwt (n = 369), V122I-associated ATTRm (n = 92) or T60A-associated ATTRm (n = 59) amyloidosis. Cardiac amyloid burden, determined by equilibrium contrast cardiac magnetic resonance imaging, was similar between patients with Perugini grade 2 and Perugini grade 3 99mTc-DPD scans but skeletal muscle/soft tissue to femur ratio was substantially higher in the latter group (P < 0.001).
99mTc-DPD scintigraphy is exquisitely sensitive for identification of cardiac ATTR amyloid, but stratification by Perugini grade of positivity at diagnosis has no prognostic significance.
高等级(佩鲁吉尼等级 2 或 3)核素骨扫描 99mTc 标记 3,3-二膦酸-1,2-丙二醇(99mTc-DPD)摄取近来已被证实对心脏转甲状腺素(ATTR)淀粉样变性具有高诊断敏感性和特异性。我们试图确定 99mTc-DPD 闪烁扫描的佩鲁吉尼分级对ATTR 淀粉样变性患者的分层是否具有预后意义。
我们在 602 例 ATTR 淀粉样变性患者中确定了从 99mTc-DPD 闪烁扫描时起的患者生存情况,包括 377 例野生型 ATTR(ATTRwt)和 225 例突变型 ATTR(ATTRm)淀粉样变性患者。根据 99mTc-DPD 扫描的佩鲁吉尼分级(0-3)对患者进行分层。确定基线时其他患者和疾病相关因素的预后意义。在整个队列中,发现佩鲁吉尼分级 0 99mTc-DPD 扫描(n=28)始终与根据共识标准不存在心脏淀粉样变性以及与佩鲁吉尼分级 1(n=28)、2(n=436)或 3(n=110)99mTc-DPD 扫描相比明显更好的患者生存率相关(P<0.005)。在 ATTRwt(n=369)、V122I 相关 ATTRm(n=92)或 T60A 相关 ATTRm(n=59)淀粉样变性患者中,1 级、2 级或 3 级 99mTc-DPD 扫描的患者之间的生存率没有差异。通过平衡对比心脏磁共振成像确定的心脏淀粉样物质负担在佩鲁吉尼分级 2 和佩鲁吉尼分级 3 99mTc-DPD 扫描的患者之间相似,但后者组的骨骼肌/软组织与股骨比显著更高(P<0.001)。
99mTc-DPD 闪烁扫描对心脏 ATTR 淀粉样变性的识别非常敏感,但在诊断时根据佩鲁吉尼分级阳性的分层没有预后意义。